The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

33 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists.EBI
Palacky University In Olomouc
Optimization of ADME Properties for Sulfonamides Leading to the Discovery of a T-Type Calcium Channel Blocker, ABT-639.EBI
Abbvie
Synthesis and biological evaluation of 2,3'-diindolylmethanes as agonists of aryl hydrocarbon receptor.EBI
University of Wisconsin
Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor.EBI
University of Utah
8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.EBI
University of Bonn
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.EBI
Harvard University
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.EBI
University of Oxford
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.EBI
University of Maryland
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.EBI
Cnrs
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.EBI
Pfizer
Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.EBI
The University of Tokyo
beta-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: improvement of solubility by disruption of molecular planarity.EBI
The University of Tokyo
Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).EBI
Cardiff University
Targeting the Aryl Hydrocarbon Receptor with Microbial Metabolite Mimics Alleviates Experimental Colitis in Mice.EBI
Palack£
Identification of triazolopyridine derivatives as a new class of AhR agonists and evaluation of anti-psoriasis effect in a mouse model.EBI
Sichuan University
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation.EBI
Max Planck Institute of Molecular Physiology
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.EBI
Indian Institute of Technology (B.H.U.)
An electrochemical device for the assay of the interaction between a dioxin receptor and its various ligands.EBI
Kyushu University
Indole scaffolds as a promising class of the aryl hydrocarbon receptor ligands.EBI
Palack£
Targeting the aryl hydrocarbon receptor with a novel set of triarylmethanes.EBI
Universitat De Val£Ncia. Av. Vicente Andr£S Estell£S
Synthesis and biological evaluation of FICZ analogues as agonists of aryl hydrocarbon receptor.EBI
University of Wisconsin-Madison
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against EBI
Glaxosmithkline
Identification of new aryl hydrocarbon receptor (AhR) antagonists using a zebrafish model.EBI
Gwangju Institute of Science and Technology
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).EBI
University of Perugia
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17?-Hydroxysteroid Dehydrogenase Type 2.EBI
University of Basel
Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.EBI
De Montfort University
Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.BDB
Mcgill University